Prevalence of psoriasis in a study of 261 patients with vitiligo;Prevalência de psoríase em estudo de 261 pacientes com vitiligo

Anais Brasileiros de Dermatologia

Volumn 80, Issue 5, 2005, Pages 489-492

  Silva De Castro, Caio César ^a,b  

^a Santa Casa de Curitiba   (Brazil)

^b NONE   (Brazil)

Author keywords

Nevus, pigmented; Psoriasis; Vitiligo

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ALOPECIA AREATA; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CHILD; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEVUS; PHOTOTHERAPY; PREVALENCE; PSORIASIS; RHEUMATOID ARTHRITIS; SCLERODERMA; THYROID DISEASE; VITILIGO;

EID: 33846650690     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/s0365-05962005000600006     Document Type: Article

References (19)

1. Koransky JS, Roenigk HHJ. Vitiligo and psoriasis. J Am Acad Dermatol. 1982; 7:183-9.
2. Menter A, Boyd AS, Silverman AK. Gutate psoriasis and vitiligo: anatomic cohabitation. J Am Acad Dermatol. 1989; 20:698-700.
3. Papadavid E, Yu RC, Munn S, Chu AC. Strict anatomical coexistence of vitiligo and psoriasis vulgaris - a Koebner phenomenon? Clin Exp Dermatol. 1996; 21:138-40.
4. Lerner AB. Vitiligo. J Invest Dermatol. 1959; 32:285-310.
5. Brandrup F, Green A The prevalence of psoriasis in Denmark. Acta Derm Venereol.1981; 61:344-6.
6. Castanet J, Ortonne JP. Pathophysiology of vitiligo. Clin Dermatol. 1997; 1:845-51.
7. Bor S, Feiwel M, Chanarin I. Vitiligo and its aetiological relationship to organ-specific autoimmune disease. Br J Dermatol. 1969; 81:83-8.
8. Dhar S, Malakar S, Dhar S. Colocalisation of vitiligo and psoriasis in a 9-year-old boy. Pediatr Dermatol. 1998; 15:242-3.
9. Halcin C, Hann SK, Kauh YC. Vitiligo following the resolution of psoriatic plaques during PUVA therapy. Int J Dermatol. 1997; 36:534-6.
10. Goodwin RG, Finlay AY, Anstey AV. Vitiligo following narrow-band TL-01 phototerapyfor psoriasis[letter]. Br J Dermatol. 2001; 144:1264-5.
11. Musset P, Bachelez M, Ilageve B, Delarbre C, Kowielsky P, Dubertret L, Gacelin G. Immune-mediated destruction of melanocytes in halo nevi is associated with the local expansion of a limited number of T cells clones. The J Immunol. 1999; 162:1789-94.
12. El Mofty AM, El Mofty M. Vitiligo: a symptom complex. Int J Dermatol. 1980; 19:23744.
13. Nath SK, Majumder PP, Nordlund JJ. Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet. 1994; 55:981-90.
14. Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes JJ, Jaramillo D, et al. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA Hum Genet. 2002; 110:33442.
15. Pietrzyk JJ, Turowski G, Kapinska-Mrowka M, Rozanski B. Family studies in psoriasis. I. Complex segregation analysis. Arch Derm Res. 1982; 273:287-94.
16. Swanbeck G, Inerot A, Martinsson T, Wahlstrom J. A population genetic study of psoriasis. Br J Dermatol. 1994; 131:32-9.
17. International Psoriasis Genetics Consortium. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am J Hum Genet. 2003; 73:430-7.
18. Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, et al. A genomewide screen for generalized vitiligo confirmation of AISl on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003; 72:15604.
19. Spritz RA Gowan K, Bennet DC, Fain PR Novel Vitiligo susceptibility loci on chromosome 7(AIS2) and 8(AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet. 2004; 74:188-91.